Amgen Secures Expanded FDA Approval for Uplizna
andi Amgen ( NASDAQ: NASDAQ: AMGN has reported that the U.S. Food and Drug Administration (FDA) has extended the approval label for Uplizna, which is now authorized as a treatment for…
Engineers Crack Mass Manufacturing of Nanoparticles for Direct Tumor Drug Delivery
Nanoparticles enveloped in polymer coatings that carry medicinal substances exhibit substantial potential for treating cancers such as ovarian cancer. These microscopic entities can be precisely directed towards tumor sites, releasing…
drug and pharmaceutical companies
drug development
healthcare and medicine
medicine and healthcare
news
Health Agency Unveils Plan to Streamline and Accelerate Medicine Approvals
The Health Ministry announced on Tuesday a new initiative aimed at streamlining and expediting the approval process for new drugs. The objective of the updated framework is to reduce the…